Home › NDC Lookup › RxCUI directory › RxCUI 1922763

Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet — RxCUI 1922763

RxNorm drug concept · Semantic clinical drug
RxCUI 1922763 Semantic clinical drug · SCD ● Current RxNorm concept 25 FDA products 41 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1922763
Official nameAtrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assotalol HCl AF 160 MG Oral Tablet
FDA products mapped25
Package NDCs mapped41
Reported Medicaid activity (SDUD)17,455 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sotalol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sotalol treats life-threatening ventricular arrhythmias. Some products also help keep a normal rhythm in people with highly symptomatic atrial fibrillation or flutter. It has not b...
  • Sotalol can cause dangerous rhythm problems, especially in the first days or after a dose increase. In the hospital your heart is monitored continuously and your kidney function is...
  • Why do I have to start it in the hospital?
  • No. Stopping suddenly can cause chest pain or even a heart attack, especially if you have heart disease. If you need to stop, your doctor will usually lower the dose over 1 to 2 we...
📖 Read our full Sotalol guide →

🕸️ Concept Web — How Atrial Fibrillation sotalol hydrochloride 160 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet RxCUI 1922763

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sotalol 9947
    • Sotalol hydrochloride 7008
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Betapace 224909
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sotalol Oral Tablet 373937
    • Sotalol hydrochloride Oral Tablet 2648136
    • Sotalol Oral Product 1161104
    • Sotalol Pill 1161105
    • Sotalol hydrochloride Oral Product 2659339
    • Sotalol hydrochloride Pill 2660941
    • Sotalol Oral Tablet [Betapace] 367639
    • Sotalol hydrochloride Oral Tablet [Betapace] 2657970
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sotalol hydrochloride 160 MG SCDC · 904578
  • Sotalol Oral Tablet SCDF · 373937
  • Sotalol hydrochloride Oral Tablet SCDFP · 2648136
  • Sotalol Oral Product SCDG · 1161104
  • Sotalol Pill SCDG · 1161105
  • Sotalol hydrochloride Oral Product SCDGP · 2659339
  • Sotalol hydrochloride Pill SCDGP · 2660941

Brand-Name Concepts

📦 FDA Products & Package NDCs

25 products · 41 package NDCs
41 package NDCs map to RxCUI 1922763 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42806-0121-01 100 TABLET in 1 BOTTLE (42806-121-01) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
42806-0121-10 1000 TABLET in 1 BOTTLE (42806-121-10) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
42806-0122-01 100 TABLET in 1 BOTTLE (42806-122-01) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
42806-0122-10 1000 TABLET in 1 BOTTLE (42806-122-10) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
42806-0123-01 100 TABLET in 1 BOTTLE (42806-123-01) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
42806-0123-10 1000 TABLET in 1 BOTTLE (42806-123-10) Sotalol hydrochloride Epic Pharma, LLC 2016-01-04
59651-0775-01 100 TABLET in 1 BOTTLE (59651-775-01) SOTALOL HYDROCHLORIDE Aurobindo Pharma Limited 2023-06-29
59651-0776-01 100 TABLET in 1 BOTTLE (59651-776-01) SOTALOL HYDROCHLORIDE Aurobindo Pharma Limited 2023-06-29
59651-0777-01 100 TABLET in 1 BOTTLE (59651-777-01) SOTALOL HYDROCHLORIDE Aurobindo Pharma Limited 2023-06-29
60505-0080-00 100 TABLET in 1 BOTTLE (60505-0080-0) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0080-01 1000 TABLET in 1 BOTTLE (60505-0080-1) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0081-00 100 TABLET in 1 BOTTLE (60505-0081-0) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0081-01 1000 TABLET in 1 BOTTLE (60505-0081-1) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0082-00 100 TABLET in 1 BOTTLE (60505-0082-0) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0082-01 1000 TABLET in 1 BOTTLE (60505-0082-1) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0159-00 100 TABLET in 1 BOTTLE (60505-0159-0) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0159-01 1000 TABLET in 1 BOTTLE (60505-0159-1) Sotalol Hydrochloride Apotex Corp. 2003-02-01
60505-0222-01 100 TABLET in 1 BOTTLE, PLASTIC (60505-0222-1) Sotalol Hydrochloride Apotex Corp. 2003-09-09
60505-0222-02 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0222-2) Sotalol Hydrochloride Apotex Corp. 2003-09-09
60505-0223-01 100 TABLET in 1 BOTTLE, PLASTIC (60505-0223-1) Sotalol Hydrochloride Apotex Corp. 2003-09-09
60505-0223-02 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0223-2) Sotalol Hydrochloride Apotex Corp. 2003-09-09
60505-0224-01 100 TABLET in 1 BOTTLE, PLASTIC (60505-0224-1) Sotalol Hydrochloride Apotex Corp. 2003-09-09
60505-0224-02 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0224-2) Sotalol Hydrochloride Apotex Corp. 2003-09-09
76385-0114-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-114-01) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-15
76385-0114-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-114-50) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-15
76385-0115-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-115-01) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-15
76385-0115-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-115-50) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-06
76385-0116-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-116-01) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-06
76385-0116-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-116-50) Sotalol UNICHEM PHARMACEUTICALS (USA), INC. 2017-12-06
76385-0125-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-125-01) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
76385-0125-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-125-50) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
76385-0126-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-126-01) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
76385-0126-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-126-50) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
76385-0127-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-127-01) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
76385-0127-50 500 TABLET in 1 BOTTLE, PLASTIC (76385-127-50) Sotalol Hydrochloride AF UNICHEM PHARMACEUTICALS (USA), INC. 2020-02-21
83107-0005-10 100 TABLET in 1 BOTTLE (83107-005-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0006-10 100 TABLET in 1 BOTTLE (83107-006-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0007-10 100 TABLET in 1 BOTTLE (83107-007-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0008-60 60 TABLET in 1 BOTTLE (83107-008-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
83107-0009-60 60 TABLET in 1 BOTTLE (83107-009-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
83107-0010-60 60 TABLET in 1 BOTTLE (83107-010-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
Observed labelers: Apotex Corp. (14) · UNICHEM PHARMACEUTICALS (USA), INC. (12) · Epic Pharma, LLC (6) · Legacy Pharma USA, Inc. (6) · Aurobindo Pharma Limited (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.